Coronavirus News Update – March 31: N.Y.C. Leads the Nation in New Covid Cases

Vaccine Hesitancy in the U.S. Falls

By Anna Breuer on 31 March 2021
  • Share

An empty Times Square, an area usually bustling with tourists

The rate of new coronavirus infections is rising faster in New York than in any other state. While new infections had been on a downward trajectory for almost three months, they then rose by 64%.  State officials reported 67,963 new cases Tuesday for the preceding seven-day period, an increase of 26,557 from the previous week.

As of early Tuesday morning, the world has recorded over 129 million Covid-19 cases since the first cases in December 2019 and it has seen 2.82 million deaths, according to Worldometer, a service which tracks such information.  In addition, over 104 million people worldwide have recovered from the virus.

Since the start of vaccinations at the end of last year, the world has administered 574 million doses, the equivalent of 7.6 doses for every 100 people as of Wednesday morning, a 0.2 percentage point increase since Tuesday.

The Centers for Disease Control and Prevention said that as of Tuesday, over 96 million people in the United States have received at least one dose of the coronavirus vaccine.  Over one-third of the population – some 95.7 million people or 37.1% of the population over the age of 18 – has received at least a first inoculation, including 53.5 million people, or 20.7% of the same population, who have received both doses. Overall, 16.1% of the population has been fully vaccinated against the virus, a 0.3 percentage point increase over Tuesday.

Three studies suggest that women who had received either the Pfizer-BioNTech or Moderna vaccines during pregnancy passed their antibodies on to their newborn children. The studies found antibodies in the women’s umbilical-cord blood, indicating the babies received the antibodies.

Meanwhile, a clinical study found that the Pfizer-BioNTech coronavirus vaccine is 100% effective against the virus in children ages 12 to 15, the two companies announced Wednesday. The placebo-controlled test found that none of the 2,260 participants who had received the real vaccine developed Covid-19.

Pfizer and BioNTech said that the two companies plan to test a Covid-19 vaccine that doesn’t require ultracold storage.  The two plan a clinical trial of a so-called lyophilized formulation vaccine in 1,100 adults ages 18 to 55 in the United States to determine if the efficacy of the lyophilized version is the same as the current version of the vaccine.

A study conducted by the U.S. Census Bureau and developed in concert with the Centers for Disease Control and Prevention and the National Center for Health Statistic found that fewer people are reluctant to get vaccinated against the coronavirus. Conducted from March 3 through March 15, the survey found that approximately 17% of adults said they would either definitely or probably note get vaccinated, a five percentage point drop from 22% in January.

(Photo: Accura Media Group)

Accura News

Read previous post:
Google to Add Support for Routes with a Low-Carbon Footprint in Maps App

Google announced that its Maps will soon default to a route that has the lowest possible carbon footprint, an effort...